🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Paúl Cordero

Outcomes Research Consortium

ORCID: 0000-0001-9236-2268

Also affiliated with Sanofi (France), Reading Museum, Thames Water (United Kingdom), Sanofi (United Kingdom), University School, University College London, Case Western Reserve University, University of Reading

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Development of a preliminary conceptual model of the patient experience of chronic kidney disease: a targeted literature review and analysis”.

Development of a preliminary conceptual model of the patient experience of chronic kidney disease: a targeted literature review and analysis

BMC Nephrology(2021)10.1186/s12882-021-02440-9
N/A
0DataRank · unranked
23 citations

Niklas Karlsson, Anna K Sundgren, Paúl Cordero, Amanda Grandinetti, Henry Cremisi +2 more

Development of a preliminary conceptual model of the patient experience of chronic kidney disease: a targeted literature review and analysis

UNC Libraries(2024)10.17615/8r91-x067
N/A
0DataRank · unranked
0 citations

Henry Cremisi, Jennifer E. Flythe, Amanda Grandinetti, Paúl Cordero, Anna Rydén +2 more

The angiotensin receptor blocker, losartan, reduces inflammation and fibrosis, and prevents relapse of fibrosis after steroid-induced remission, in mice prone to Crohn’s disease-like ileitis

Journal of Crohn s and Colitis(2025)10.1093/ecco-jcc/jjaf083
N/A
0DataRank · unranked
8 citations

Shuvra Ray, Joseph Jay Williams, Kenan Akbulut, Paúl Cordero, A. M. Gómez-Uriz +13 more